Vipul Organics Enters Water Treatment Segment with Membranes; Aims for 25% Revenue Contribution

Synopsis: Vipul Organics has commenced commercial sales of membranes through its AdiMem unit, aiming to generate 25% of its total revenue from this segment within three years, marking a strategic shift beyond its core chemicals business.

Vipul Organics has a total market capitalization of Rs. 375.37  crore, according to data on the BSE. The stock was listed on the exchanges in April, 1995. Vipul Organics shares were trading at Rs. 197 apiece on the Bombay Stock Exchange; the stock has declined around 7 percent over the last five sessions, while it has surged about 12.22 percent in the 30 days. Over a six month period, the stock has given a return of 7.30 percent, whereas on a year-on-year basis it has rallied nearly 44.53 percent, reflecting good overall performance. The stock’s 52-week high was Rs. 249 and 52-week low was Rs. 116.

Vipul Organics Limited has taken a significant step in diversifying its business by announcing that its subsidiary, AdiMem Technologies, has begun commercial sales of membranes, transitioning from pilot operations to full scale production. This move positions the company as a fully indigenous membrane manufacturer in India, reducing dependence on imports and opening up new growth avenues in the water treatment and filtration segment.

The company has set an ambitious target of generating 25 percent of its total revenue from membrane and membrane based solutions within the next three years, indicating a strong push into this high growth segment. The membranes will be used in applications such as effluent treatment plants (ETP), sewage treatment plants (STP) and industrial water recycling systems, catering to sectors like chemicals, pharmaceuticals and manufacturing.

This strategic expansion comes at a time when the membrane technology market in India is witnessing rapid growth, driven by increasing environmental regulations, water scarcity concerns and initiatives such as zero liquid discharge (ZLD) norms and river cleaning programs. The domestic membrane market is projected to grow at a CAGR of over 11 percent, with significant demand expected from industrial water treatment and recycling applications.

AdiMem’s manufacturing facility integrates production, quality control  and performance testing, enabling end to end solutions and consistent product performance at scale. The company’s product portfolio includes a wide range of membrane technologies such as RO, NF, UF and MBR systems, offering comprehensive filtration solutions. Additionally, these membranes are capable of achieving up to 90 percent water recovery, aligning with sustainability goals and regulatory requirements.

For Vipul Organics, traditionally known for its pigments, dyes and specialty chemicals business, this marks a strategic shift toward higher value and technology driven segments. The company, which reported annual revenues of around Rs. 160–170 crore in recent years, is now positioning itself to tap into a much larger opportunity, including the broader global filtration and membrane market estimated in billions of dollars.

Overall, the launch of commercial membrane sales signals a major strategic transformation for Vipul Organics, positioning the company to benefit from the growing demand for sustainable water management solutions and strengthening its long term growth outlook.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Vipul Organics Enters Water Treatment Segment with Membranes; Aims for 25% Revenue Contribution appeared first on Trade Brains.